Sign in
  1. Home
  2. Companies
  3. Chemed Corporation
  4. Financial Ratios
Chemed Corporation logo
Chemed Corporation CHE
$ 519.84 0.09%
report update icon

Quarterly report 2026-Q2
added 07-31-2026

Chemed Corporation Financial Ratios 2025-2007 | CHE

Brief overview of Chemed Corporation's financial ratios

Ratios are assessed across five available annual reports in the 2020–2024 interval.

The latest available valuation ratios are P/E 29.69x (median 29.69x), EV/EBITDA 19.95x (median 18.17x), P/S 3.69x (median 3.75x). The multiple basket looks neutral against its history, differing from median levels by roughly -1.7%.

Earnings yield calculated as 1/P/E is about 3.4%, showing current profit per unit of share price.

The latest available business-quality ratios are ROE 27%, ROA 18.1%, ROCE 32.8%. Profitability forms a strong profile, with capital and assets producing substantial returns.

The PEG ratio is 3.21x; investors pay a high price per unit of expected growth.

The cash cycle changed only slightly and ended at 16.3 days.

Overall picture

Chemed Corporation's multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.

Annual Financial Ratios Chemed Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

P/E

 30962.7 29687.9 34544.8 32080.5 27.3 25.8 35.0 23.2 43.4 24.8 21.5 17.5 18.8 16.0 13.5 15.5 12.0 12.4 -

P/S

 3.2 3.7 4.2 3.8 3.4 4.0 4.0 2.7 2.6 1.7 1.5 1.2 1.0 1.0 0.9 - - - -

EPS

 18.4 20.1 18.1 16.7 17.1 20.0 13.8 12.8 6.1 6.6 6.5 5.8 4.2 4.7 4.2 3.6 3.3 2.9 -

EV (Enterprise Value)

 8.7 B 9.34 B 9.71 B 8.58 B 8.02 B 8.6 B 8.23 B 5.14 B 4.63 B 3.04 B 2.69 B 2.13 B 1.81 B 1.77 B 1.5 B 1.58 B 1.12 B 828 M -4.99 M

EBITDA per Share

 28 28.6 26.7 27 25.7 28 19.5 17.7 14.9 13 12.9 11.7 10.6 9.88 8.93 7.43 6.59 6.7 -

EV/EBITDA

 21.6 21.7 24.2 21.3 19.9 18.0 25.0 17.1 18.2 13.1 11.2 9.3 8.1 8.2 7.0 9.4 7.5 5.4 -

PEG

 178055.27 3211.51 3490.8 2322.91 1.74 1.47 4.62 0.21 -5.44 16.23 1.66 0.48 -1.85 1.27 0.86 - - - -

P/B

 8.4 8.0 8.5 10.0 11.8 9.1 10.6 8.1 7.9 5.1 4.6 3.8 3.2 3.2 2.8 2.7 1.9 - -

P/CF

 21.2 21.5 28.5 25.8 23.8 16.8 31.0 20.3 43.4 28.2 18.6 26.0 12.0 14.8 8.0 14.7 5.5 7.4 -

ROE %

 0.03 0.03 0.02 0.03 43.09 35.45 30.27 34.76 18.17 20.75 21.49 22.00 17.20 19.70 20.78 17.71 15.46 16.95 -

ROA %

 0.02 0.02 0.02 0.02 20.00 22.26 17.34 21.07 10.67 12.36 12.94 11.55 8.64 10.39 10.80 9.86 9.00 - -

ROCE %

 34.54 32.75 30.74 43.01 55.04 43.24 26.49 31.25 28.07 25.24 27.09 24.61 30.13 22.26 23.63 31.06 26.48 33.48 -

Current Ratio

 2.8 3.0 3.0 2.2 1.9 2.7 0.7 0.8 0.9 1.0 0.9 1.0 0.6 1.3 1.0 2.3 2.4 - -

DSO

 25.5 26.5 25.9 23.6 22.5 23.8 27.1 24.5 24.9 30.6 25.1 31.2 23.7 23.8 21.5 - - - -

DIO

 1.7 2.3 2.8 2.7 2.3 1.9 2.1 1.7 1.7 1.9 2.1 2.2 2.4 2.5 3.3 3.1 1.6 - -

DPO

 11.6 12.5 13.2 15.3 17.0 13.9 14.1 14.9 15.3 13.0 14.7 16.5 15.1 17.1 18.1 21.7 11.4 - -

Operating Cycle

 27.2 28.8 28.6 26.4 24.8 25.7 29.1 26.2 26.6 32.4 27.2 33.4 26.1 26.3 24.8 3.1 1.6 - -

Cash Conversion Cycle

 15.6 16.3 15.4 11.1 7.9 11.7 15.0 11.3 11.2 19.5 12.6 16.9 11.0 9.2 6.7 -18.7 -9.7 - -

All numbers in USD currency

Quarterly Financial Ratios Chemed Corporation

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2

EPS

 5.14 4.85 4.46 3.6 4.91 5.04 4.7 4.3 4.97 3.54 3.62 - 3.82 4.45 4.28 - 4.62 3.57 4.08 - 4.25 5.16 3.5 - 3.69 3.18 2.8 - 3.19 3.43 2.79 - 2.22 -1.35 1.84 - 1.66 1.51 1.49 - 1.71 1.6 1.45 - 1.44 1.41 1.17 - 0.96 0.79 1.2 - 1.1 1.12 1.08 - 1.06 0.96 0.86 0.93 0.83

EBITDA per Share

 9.34 7.42 6.14 5.6 7.58 7.01 6.71 5.83 6.61 5.45 5.85 - 6.25 7.01 6.94 - 8.83 5.39 5.91 - 7.31 7.59 5.83 - 6.01 5.4 3.74 - 5.63 4.81 4.08 - 5.05 -1.32 3.11 - 4.25 3.38 3.16 - 4.43 3.61 2.88 - 3.79 3.35 2.5 - 1.99 1.76 2.46 - 2.24 2.42 2.17 - 2.3 2 1.75 1.91 1.77

ROE %

 26.32 24.24 22.55 22.46 23.57 24.85 24.33 24.60 26.99 29.34 33.36 27.21 36.44 35.05 32.39 22.77 30.28 30.16 29.87 22.83 30.94 30.41 27.44 21.24 29.91 31.09 31.72 25.57 32.13 19.46 15.68 8.07 13.19 11.38 20.13 14.61 20.22 20.36 20.39 15.65 21.10 20.88 20.18 15.40 19.29 17.09 16.66 12.10 16.70 17.51 18.77 13.80 19.09 19.40 19.08 14.57 18.50 16.89 4.38 3.93 3.68

ROA %

 15.62 15.49 15.45 15.58 16.29 16.93 16.19 15.89 16.32 16.44 18.35 14.57 18.65 14.46 18.95 14.03 18.75 19.01 18.82 14.34 18.98 18.26 16.06 12.17 17.42 18.41 19.02 15.50 19.35 11.75 9.35 4.74 7.79 6.77 11.94 8.70 12.08 12.20 12.25 9.43 12.29 11.74 10.96 8.08 10.04 8.81 8.47 6.08 8.50 9.03 9.77 7.28 10.03 10.15 9.95 7.57 9.91 9.34 2.27 2.34 2.18

ROCE %

 33.34 30.62 28.10 28.46 28.89 29.39 29.23 30.21 35.30 40.21 46.31 38.04 49.95 46.97 42.21 28.80 37.05 35.43 36.00 27.34 36.28 37.05 33.57 24.76 35.20 36.10 36.61 29.81 39.80 22.15 19.99 10.46 18.64 15.96 31.64 23.97 33.74 34.25 34.83 26.36 35.27 34.70 34.13 26.23 32.74 29.59 29.05 20.93 28.87 31.08 33.03 24.37 34.36 35.09 33.75 26.03 32.92 29.54 7.38 6.89 6.60

Current Ratio

 2.1 2.2 3.0 3.3 3.2 3.3 3.3 3.2 2.9 2.7 2.6 2.2 2.1 - 2.0 1.9 2.5 2.7 2.8 2.7 2.7 2.7 2.7 2.3 2.3 2.3 2.3 2.5 2.5 2.5 2.5 2.4 2.4 2.4 2.4 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.1 2.1 2.1 2.1 2.0 2.0 2.0 2.0 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.5 2.5

DSO

 27.4 29.9 29.2 34.7 34.0 28.7 27.7 26.7 23.3 22.6 23.9 - 10.5 10.1 21.9 - 20.5 19.6 20.0 - 21.9 23.1 23.9 - 27.3 27.7 26.0 - 24.6 24.7 24.2 - 24.8 25.0 27.6 - 30.7 30.9 27.9 - 25.1 25.4 28.0 - 31.7 31.6 27.6 - 24.6 23.4 23.0 - 24.0 24.1 22.1 - 20.8 21.3 25.3 - -

DIO

 1.5 1.6 1.9 1.8 1.9 2.4 2.5 2.8 3.0 2.7 2.6 - 1.4 1.4 2.8 - 2.1 1.9 1.9 - 1.9 1.8 1.9 - 2.1 2.1 1.9 - 1.7 1.7 1.6 - 1.7 1.7 1.8 - 1.9 1.9 2.0 - 2.1 2.1 2.1 - 2.2 2.2 2.3 - 2.5 2.4 2.4 - 2.5 2.5 2.8 - 3.2 3.3 3.2 3.2 -

DPO

 15.2 11.8 10.6 10.4 9.8 10.1 11.6 13.3 12.3 9.9 10.1 - 10.2 8.8 18.7 - 15.5 14.5 14.7 - 14.6 14.1 13.7 - 14.2 14.4 14.3 - 15.0 15.0 14.8 - 15.3 15.4 14.1 - 12.8 13.1 13.7 - 14.7 14.7 15.4 - 16.7 16.6 15.7 - 15.7 14.9 15.6 - 17.2 17.2 17.1 - 18.0 18.4 19.4 20.4 -

Operating Cycle

 - 31.5 31.1 36.5 35.9 31.1 30.2 29.5 26.4 25.3 26.5 - 11.9 11.5 24.7 - 22.6 21.4 21.9 - 23.8 24.9 25.8 - 29.4 29.8 27.9 - 26.3 26.4 25.9 - 26.5 26.7 29.4 - 32.5 32.8 29.8 - 27.2 27.5 30.1 - 33.9 33.8 29.8 - 27.1 25.8 25.4 - 26.5 26.6 24.9 - 24.1 24.6 - - -

Cash Conversion Cycle

 - 19.8 20.5 26.1 26.1 21.0 18.6 16.1 14.1 15.4 16.4 - 1.8 2.7 6.0 - 7.1 6.9 7.2 - 9.2 10.8 12.2 - 15.2 15.4 13.5 - 11.3 11.4 11.1 - 11.2 11.2 15.3 - 19.7 19.7 16.2 - 12.6 12.8 14.7 - 17.2 17.1 14.2 - 11.4 10.9 9.8 - 9.3 9.4 7.8 - 6.1 6.3 - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Chemed Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
Мать и Дитя Мать и Дитя
MDMG
 		- - - russiaRussia
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
 		- -2.09 % $ 216 M usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
 		- 3.54 % $ 1.5 B usaUSA
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
 		- 10.96 % $ 46.2 M chinaChina
ЮМГ ЮМГ
GEMC
 		- - - russiaRussia
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
 		$ 4.68 1.08 % $ 613 M chinaChina
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
 		- -0.32 % $ 98.4 M usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
 		$ 22.66 0.85 % $ 6.6 B germanyGermany
LHC Group LHC Group
LHCG
 		- - $ 5.27 B usaUSA
Oak Street Health Oak Street Health
OSH
 		- 0.03 % $ 9.53 B usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
 		- - $ 68.1 M usaUSA
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
 		- 26.45 % $ 70.6 M usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
 		$ 28.13 0.67 % $ 2.55 B usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
 		$ 118.76 0.06 % $ 2.14 B usaUSA
Amedisys Amedisys
AMED
 		- 0.01 % $ 3.3 B usaUSA
Apollo Medical Holdings Apollo Medical Holdings
AMEH
 		- -2.11 % $ 1.84 B usaUSA
AMN Healthcare Services AMN Healthcare Services
AMN
 		$ 33.8 1.3 % $ 1.3 B usaUSA
American Shared Hospital Services American Shared Hospital Services
AMS
 		$ 1.43 1.39 % $ 9.46 M usaUSA
Brookdale Senior Living Brookdale Senior Living
BKD
 		$ 11.77 0.08 % $ 2.77 B usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
 		$ 13.27 0.08 % $ 1.24 B britainBritain
Community Health Systems Community Health Systems
CYH
 		$ 2.89 0.34 % $ 386 M usaUSA
DaVita DaVita
DVA
 		$ 183.99 1.19 % $ 13.7 B usaUSA
Encompass Health Corporation Encompass Health Corporation
EHC
 		$ 121.79 0.01 % $ 12.2 B usaUSA
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
 		$ 24.5 0.33 % $ 12.2 B usaUSA
The Ensign Group The Ensign Group
ENSG
 		$ 170.79 0.22 % $ 9.79 B usaUSA
HCA Healthcare HCA Healthcare
HCA
 		$ 405.0 1.78 % $ 95.7 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
 		$ 21.82 0.51 % $ 1.58 B usaUSA
Hanger Hanger
HNGR
 		- - $ 732 M usaUSA
IMAC Holdings IMAC Holdings
IMAC
 		- -1.77 % $ 25.4 M usaUSA
The Joint Corp. The Joint Corp.
JYNT
 		$ 8.32 0.48 % $ 126 M usaUSA
MEDNAX MEDNAX
MD
 		$ 27.03 0.52 % $ 2.27 B usaUSA
ModivCare ModivCare
MODV
 		- -25.23 % $ 6.12 M usaUSA
National HealthCare Corporation National HealthCare Corporation
NHC
 		$ 218.64 0.01 % $ 3.38 B usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
 		- -13.87 % $ 1.52 M usaUSA
Option Care Health Option Care Health
OPCH
 		$ 24.21 2.56 % $ 3.92 B usaUSA
Ontrak Ontrak
OTRK
 		- -11.98 % $ 1.53 M usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
 		$ 38.25 0.06 % $ 1.55 B usaUSA
The Pennant Group The Pennant Group
PNTG
 		$ 38.0 1.8 % $ 1.31 B usaUSA
Regional Health Properties Regional Health Properties
RHE
 		- - $ 5.2 M usaUSA
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
 		- - $ 2.02 B usaUSA
Surgery Partners Surgery Partners
SGRY
 		$ 14.26 0.64 % $ 1.81 B usaUSA
Sanara MedTech Sanara MedTech
SMTI
 		$ 34.73 0.03 % $ 299 M usaUSA
SunLink Health Systems SunLink Health Systems
SSY
 		- 17.98 % $ 7.81 M usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
 		$ 265.05 0.59 % $ 23.9 B usaUSA
Tivity Health Tivity Health
TVTY
 		- 0.09 % $ 1.6 B usaUSA
Universal Health Services Universal Health Services
UHS
 		$ 169.65 0.31 % $ 10.8 B usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
 		$ 79.35 0.9 % $ 1.2 B usaUSA